SCHEMBL27884205

SCHEMBL27884205

C=CC(c1ccc(C(C)C)cc1)S(=O)(=O)n1c(Cc2ccc(C(=O)O)c(F)c2)cc2cc(Cl)ccc21

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 10/20 0.35
▸ PPARA Q07869 7/20 0.35
▸ PPARD Q03181 7/20 0.35
▸ ACLY P53396 3/20 0.34
▸ PSEN1 P49768 1/20 0.34
▸ PSEN2 P49810 1/20 0.34
▸ APH1B Q8WW43 1/20 0.34
▸ NCSTN Q92542 1/20 0.34
▸ APH1A Q96BI3 1/20 0.34
▸ PSENEN Q9NZ42 1/20 0.34
▸ PLA2G4A P47712 1/20 0.33
▸ CXCR3 P49682 1/20 0.33
▸ CACNA1G O43497 1/20 0.33
▸ CACNA1H O95180 1/20 0.33
▸ CACNA1I Q9P0X4 1/20 0.33
▸ CCR2 P41597 1/20 0.32
▸ PHGDH O43175 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27884222 0.89 PPARG (0.37) PPARGPPARAPPARDACLYPSEN1
SCHEMBL28797216 0.88 PHGDH (0.41) PPARGPPARAPPARDACLYPSEN1
SCHEMBL27884309 0.86 PPARG (0.32) PPARGPPARAPPARDACLYPSEN1
SCHEMBL27867732 0.85 CCR2 (0.45) PPARGPPARAPPARDACLYCCR2
SCHEMBL12096673 0.85 PPARG (0.49) PPARGPPARAPPARDACLYPSEN1
SCHEMBL27884203 0.82 PPARG (0.34) PPARGPPARAPPARDACLYPLA2G4A
SCHEMBL27867735 0.81 ACLY (0.42) PPARGPPARAPPARDACLYPLA2G4A
SCHEMBL27884472 0.81 PHGDH (0.39) PPARGPPARAPPARDACLYPLA2G4A
SCHEMBL27884365 0.80 ACLY (0.40) PPARGPPARAPPARDACLYPLA2G4A
SCHEMBL28800052 0.79 ACLY (0.43) PPARGPPARAPPARDACLYPLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102596906-A Use of indole derivatives as NURR-1 activators as agents for the treatment of Parkinson's disease FOURNIER LAB SA 2012-07-18 — — CN disclosed
Send feedback